Coronavirus Update - 09th November 2020

We would like to reassure our customers that as England enters its second national lockdown period, we remain open for business and at full capacity as we have done since the start of this pandemic and fully comply with all government guidance on minimising the risks of COVID-19.

As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

Accelerated Formulation Case Study Released

The challenge for Arcinova was to develop in a short space of time an injectable aqueous solution formulation: The drug substance was thought to be completely insoluble in water so background (client supplied) information was minimal as they had never prepared a liquid formulation of this particular drug substance before. The target formulation concentration was very low (<10 µg/mL).

Find out more here

#CaseStudy #DrugProduct


Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.